Pharma Services Valuation

Healthcare & Life Sciences
Pharma Services M&A: Market Drivers, Valuation, and Buyer Underwriting
ByAuxo Capital AdvisorsJune 19, 2026
A buyer-led guide to pharma services M&A covering CROs, CDMOs, testing, commercialization services, buyer underwriting, valuation pressure points, capital alternatives, diligence, and seller readiness.
Read More Pharma Services M&A: Market Drivers, Valuation, and Buyer Underwriting
Healthcare & Life Sciences
Pharma Services Company Valuation: What Are CROs and CDMOs Worth?
ByAuxo Capital AdvisorsJune 19, 2026June 20, 2026
A buyer-focused guide to pharma services company valuation covering normalized EBITDA, CRO and CDMO business-model differences, backlog, sponsor quality, capacity, capex, valuation methods, deal structure, and seller proceeds.
Read More Pharma Services Company Valuation: What Are CROs and CDMOs Worth?